Jane Street
LABU icon

Jane Street’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Jane Street’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Buy
+1,921
New +$368K ﹤0.01% 7731
2025
Q2 		– Sell
-73,118
Closed -$3.88M – 10319
2025
Q1 		$4.46M Buy
+73,118
New +$6.23M ﹤0.01% 3097
2024
Q4 		– Sell
-6,122
Closed -$720K – 10044
2024
Q3 		$788K Buy
+6,122
New +$799K ﹤0.01% 6344
2024
Q1 		– Sell
-81,349
Closed -$9.92M – 9684
2023
Q4 		$9.92M Buy
81,349
+80,572
+10,370% +$6.16M ﹤0.01% 1970
2023
Q3 		$59.2K Sell
777
-352
-31% -$36.1K ﹤0.01% 8115
2023
Q2 		$134K Sell
1,129
-2,195
-66% -$274K ﹤0.01% 7869
2023
Q1 		$326K Sell
3,324
-32,935
-91% -$4.47M ﹤0.01% 7053
2022
Q4 		$5.13M Buy
36,259
+35,588
+5,304% +$4.96M ﹤0.01% 2438
2022
Q3 		$94K Buy
671
+53
+9% +$9.71K ﹤0.01% 8676
2022
Q2 		$83K Sell
618
-13,860
-96% -$2.36M ﹤0.01% 8740
2022
Q1 		$4.54M Buy
14,478
+14,141
+4,196% +$5.33M ﹤0.01% 3187
2021
Q4 		$242K Buy
337
+119
+55% +$114K ﹤0.01% 8534
2021
Q3 		$241K Sell
218
-2,212
-91% -$2.72M ﹤0.01% 8576
2021
Q2 		$3.58M Sell
2,430
-3,202
-57% -$4.44M ﹤0.01% 3240
2021
Q1 		$8.89M Buy
+5,632
New +$13.2M ﹤0.01% 1675
2020
Q4 		– Sell
-257
Closed -$410K – 7821
2020
Q3 		$275K Sell
257
-2,489
-91% -$2.85M ﹤0.01% 6010
2020
Q2 		$3.26M Sell
2,746
-2,617
-49% -$2.27M ﹤0.01% 2388
2020
Q1 		$2.42M Buy
5,363
+4,766
+798% +$4.34M ﹤0.01% 1828
2019
Q4 		$687K Buy
+597
New +$536K ﹤0.01% 3278
2019
Q3 		– Sell
-5,731
Closed -$4.76M – 5458
2019
Q2 		$5.75M Buy
5,731
+1,600
+39% +$1.55M 0.01% 959
2019
Q1 		$4.95M Buy
4,131
+3,063
+287% +$3.19M 0.01% 1154
2018
Q4 		$702K Buy
1,068
+206
+24% +$216K ﹤0.01% 3038
2018
Q3 		$1.6M Buy
+862
New +$1.69M ﹤0.01% 2146
2018
Q1 		– Sell
-1,515
Closed -$2.82M – 5140
2017
Q4 		$2.36M Sell
1,515
-4,096
-73% -$6.27M 0.01% 1443
2017
Q3 		$9.59M Buy
5,611
+4,775
+571% +$6.63M 0.03% 536
2017
Q2 		$1.05M Sell
836
-613
-42% -$618K ﹤0.01% 2147
2017
Q1 		$1.38M Buy
1,449
+995
+219% +$887K 0.01% 1708
2016
Q4 		$284K Sell
454
-296
-39% -$222K ﹤0.01% 3409
2016
Q3 		$731K Sell
750
-8,654
-92% -$7.14M ﹤0.01% 2333
2016
Q2 		$5.31M Buy
9,404
+8,239
+707% +$5.16M 0.03% 599
2016
Q1 		$639K Sell
1,165
-94
-7% -$59.5K ﹤0.01% 2326
2015
Q4 		$2.13M Buy
1,259
+745
+145% +$1.21M 0.01% 1012
2015
Q3 		$668K Buy
+514
New +$1.57M ﹤0.01% 2004

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Jane Street's LABU Position: Q2 2026 in Review

Jane Street opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 1,921 shares worth $561K. The stake represents ﹤0.01% of the portfolio and ranks #7731 among its holdings. This is a return to the name: Jane Street previously reported a position in LABU as recently as Q1 2025.

Jane Street first reported a position in LABU in Q3 2015 and has held it in 33 quarters since. The position peaked at $9.92M in Q4 2023. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Jane Street held 1,921 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $561K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Jane Street position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7731 holding.
  • Jane Street first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and has held it in 33 quarters since.
  • Jane Street's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.92M in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.